This content is machine translated Multiple Sclerosis: RRMS Therapy change – strategy for follow-up treatment Until the individually appropriate disease-modifying therapy (DMT) is available, there arein the absence of predictive biomarkers, stepwise optimizations are often necessary, possibly resulting in multiple changes of DMT. To reduce…
View Post 6 min This content is machine translated Late-onset MS and age-correlated effects. “Time matters” In recent years, late-onset MS and age-correlated effects on disease progression have become an increasing focus of interest. There are many new findings, but also some unanswered questions.
